title: [Prostate cancer and disseminated intravascular coagulation: review of the literature].
abstract: Disseminated intravascular coagulation is a rare complication of prostatic cancer evolution. Occurring on hormonorefractory phase, it remains most often infraclinic. Cases of acute, severe intravascular disseminated coagulation at first presentation are life-threatening because of hemorragic and thrombotic complications, justifying emergency medical treatment. In the light of a review of literature, we insist on epidemiological features, physiopathology and therapeutics of intravascular disseminated coagulation. In spite of a pejorative prognosis, this could help to achieve a period of remission.
authors.affiliation: Service d'oncologie radiothérapie, hôpital d'instruction des armées du Val-de-Grâce, 74, boulevard de Port-Royal, 75230 Paris, France. chargari-vdg@hotmail.fr <chargari-vdg@hotmail.fr>
authors.forename: C
authors.initials: C
authors.lastname: Chargari
authors.forename: L
authors.initials: L
authors.lastname: Vedrine
authors.forename: O
authors.initials: O
authors.lastname: Bauduceau
authors.forename: S
authors.initials: S
authors.lastname: Le Moulec
authors.forename: M
authors.initials: M
authors.lastname: Fayolle
authors.forename: B
authors.initials: B
authors.lastname: Ceccaldi
authors.forename: A
authors.initials: A
authors.lastname: Houlgatte
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001706:Biopsy; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D008297:Male; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D013927:Thrombosis / Q000209:etiology
chemical_list: D000925:Anticoagulants; D000970:Antineoplastic Agents